AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
AUSTRALIA'S PEPLIN BIOTECH RAISES US$2.27 MLN IN SHARE PLACEMENT.
BRISBANE, June 2 Asia Pulse - Shares in Peplin Biotech Ltd (ASX:PEP) have jumped more than five per cent after the company raised A$3.5 million (US$2.27 million) in a share placement to accelerate its anti-cancer drug research candidate.
Peplin shares are up four cent or 5.4 per cent to 78 cents at 1053 AEST.
The Brisbane-based biotech also said its lucrative deal with an international pharmaceutical company to develop its topical anti-skin cancer drug was on-time and on-budget.
The licensing partnership with Californian-based Allergan Inc was potentially worth more than A$40 million (US$25.95 million) within five years, plus royalties.
Under the terms of the agreement, Allergan has an exclusive licence to develop and commercialise Peplin's leading anti-cancer compound, PEP005, for the treatment of skin and eye conditions in North and South America.
Peplin Biotech chairman Cherrell Hirst said it had been a busy six months for the company, after signing the first ever licence of an Australian anti-cancer drug with ...
- PEPLIN BIOTECH SET FOR STRONG DEBUT IN AUSTRALIA.
- News wire article from: AsiaPulse News September 15, 2000 700+ words
BRISBANE, Sept 15 Asia Pulse - Peplin Biotech Ltd, an Australian life sciences...the opportunity to invest in Peplin Biotech and be part of their future...Mr Redlich said that once Peplin Biotech had listed, it would seek...
- AUSTRALIA'S PEPLIN BIOTECH FILES IND APPLICATIONS WITH FDA.
- News wire article from: AsiaPulse News March 23, 2004 700+ words
SYDNEY, March 23 Asia Pulse - Peplin Biotech announced the filing of investigational new drug (IND) applications with the US...keratosis affects about 50 per cent of Caucasians who are older than 40 years of age. ASIA PULSE 23-03 1911
- AUSTRALIA'S PEPLIN BIOTECH TO RAISE US$4.1 MLN BEFORE LISTING.
- News wire article from: AsiaPulse News August 21, 2000 700+ words
BRISBANE, Aug 21 Asia Pulse - Peplin Biotech, a Queensland-based life sciences research and development company, is set to raise $A7 million ($US4.12 million) ahead...
- AUSTRALIA'S PEPLIN BIOTECH DEVELOPS NEW CANCER TREATMENT.
- News wire article from: AsiaPulse News July 24, 2001 700+ words
BRISBANE, July 24 Asia Pulse - Brisbane-based firm Peplin Biotech Ltd (ASX:PEP) has taken...diseases, including HIV. Peplin Biotech today lodged three international...research. At 1143 AEST Peplin Biotech shares were up 9.4 cents...
- AUSTRALIA'S PEPLIN BIOTECH SEEKS US$3.88 MLN VIA SHARE PLACEMENT.
- News wire article from: AsiaPulse News October 6, 2003 700+ words
BRISBANE, Oct 6 Asia Pulse - Anti-cancer drug developer Peplin Biotech Ltd (ASX:PEP) will seek to raise A$5.72 million (US$3...October. Shares in Peplin were up two cents to 92 cents at 1140 AEST. ASIA PULSE 06-10 1453
- SHARES IN AUSTRALIA'S PEPLIN BIOTECH JUMP 12% ON DISCOVERY.
- News wire article from: AsiaPulse News September 25, 2001 700+ words
SYDNEY, Sept 25 Asia Pulse - Shares in Australia's Peplin Biotech Ltd (ASX:PEP) leapt 12 per cent today after it announced the discovery of a new area of cancer treatment. The Brisbane-based...
- AUSTRALIA'S PEPLIN BIOTECH TO TEST WEED-BASED CANCER DRUG.
- News wire article from: AsiaPulse News November 8, 2002 700+ words
BRISBANE, Nov 8 Asia Pulse - A molecule found in a garden weed...for a listed Queensland company. Peplin Biotech Ltd (ASX:PEP) managing director...Petty Spurge to treat themselves. ASIA PULSE 08-11 1305
- Peplin Biotech raises A$4.3 million in rights issue.
- News wire article from: Australasian Business Intelligence September 29, 2002 700+ words
...Financial Markets Newsletter - INSTO - ABIX via COMTEX) -- Peplin Biotech attained $A4.3 million from its rights issue which ended...01 to $A0.71. Publication Date: 27 September 2002 PEPLIN BIOTECH LIMITED - ASX PEP All copyright subsisting under the Copyright...
